Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Psoriasis lesion is divided into two parts. Half of the lesion will apply cream containing sericin and turmeric and another will apply steroid cream (control). The samples will be apply two times a day for 8 weeks. Psoriasis area and severity index, physician global assessment, body surface area of lesion, dermatology life quality index, Itching score, adverse reaction are evaluated before, after using the samples for 4 and 8 weeks.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Sericin extract and turmeric extract cream | Experimental | Apply the sample 2 times a day for 8 weeks |
|
| Triamcinolone acetonide 1% cream | Active Comparator | Apply the sample 2 times a day for 8 weeks |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Sericin extract and turmeric extract cream | Drug | Apply the sample 2 times a day for 8 weeks |
|
| Measure | Description | Time Frame |
|---|---|---|
| Psoriasis Area and Severity Index | Physician will evaluate the psoriasis lesion using Psoriasis Area and Severity Index. The score is graded 0 to 72 (low score means less severity and high score means high severity). | 8 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Physician Global Assessment | Physician will evaluate the psoriasis lesion using Physician Global Assessment score (0 to 6, 0 means completely cleared, except for possible residual nonerythematous discoloration and 6 means condition worsened). | 8 weeks |
| Body surface area of lesion |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D011565 | Psoriasis |
| ID | Term |
|---|---|
| D017444 | Skin Diseases, Papulosquamous |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D047030 | Sericins |
| D014222 | Triamcinolone Acetonide |
| ID | Term |
|---|---|
| D047011 | Silk |
| D001704 | Biopolymers |
| D011108 | Polymers |
| D046911 | Macromolecular Substances |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Triamcinolone acetonide 1% Cream | Drug | Apply the sample 2 times a day for 8 weeks |
|
Physician will evaluate body surface area of psoriasis lesion in percentage. (low percentage means the lesion area decrease and high percentage means the lesion area increase). |
| 8 weeks |
| Dermatology Life Quality Index | Patients will assess dermatology life quality score (0 to 30, 0 means high life quality and 30 means low life quality). | 8 weeks |
| Itching score | Patients will assess itching score using visual analogue scale (0 to 10, 0 means low severity and 10 means high severity). | 8 weeks |
| D060829 |
| Arthropod Proteins |
| D011506 | Proteins |
| D000602 | Amino Acids, Peptides, and Proteins |
| D014221 | Triamcinolone |
| D011245 | Pregnadienes |
| D011278 | Pregnanes |
| D013256 | Steroids |
| D000072473 | Fused-Ring Compounds |
| D011083 | Polycyclic Compounds |
| D013259 | Steroids, Fluorinated |